Рус  /  Eng

Therapeutic Apheresis Technology

Phone.: +7 (495) 414-68-15

Products Catalog

Products «Immunoadsorption columns LDL Lipopak and Lp(a) Lipopak»

LDL Lipopak® columns are designed for reduction of LDL cholesterol in patients with homozygous and heterozygous familial hypercholesterolemia, which do not, or not sufficiency respond to diet and/or other therapeutic measures. LDL apheresis with LDL Lipopak® is advisable also for the patients after coronary artery bypass graft surgery and coronary angioplasty to prevent the restenosis formation.

 

Lp (a) Lipopak® columns is an unique product intended for use in therapeutic procedure called Lp(a) apheresis.

 

The numerous studies provide the epidemiological evidence that lipoprotein (a) {Lp(a)} is an independent risk factor in the pathogenesis of cardio heart disease and arteriosclerosis. The individual plasma level is genetically determined. Diet or available drugs do not influence the plasma level of Lp(a). Until today there is only one device available on the market, which allows the specific removal of Lp(a) from plasma - Lp(a) Lipopak® columns. As with LDL-Apheresis in homozygotes specific Lp(a)-Apheresis is a life saving therapy in severe cases with elevated Lp(a) as the sole risk factor.